LUNG NON-SMALL CELL CARCINOMA
Clinical trials for LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can grid radiation revive immunotherapy in lung cancer?
Disease control TerminatedThis early study tested whether combining the immunotherapy drug durvalumab with a special type of radiation called grid therapy could help people with non-small cell lung cancer whose cancer had stopped responding to durvalumab alone. Only 4 patients were enrolled before the stu…
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Light therapy boosts immune attack on lung cancer? early trial halted
Disease control TerminatedThis early-phase trial tested whether a light-activated drug (photodynamic therapy) could help immunotherapy work better in patients with non-small cell lung cancer that has spread to the lining of the lung or with mesothelioma. Only 5 people took part, and the study was stopped …
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC